66 related articles for article (PubMed ID: 21220758)
1. The effect of decreasing renal function on lipoprotein profiles.
Attman PO; Samuelsson O; Alaupovic P
Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
[TBL] [Abstract][Full Text] [Related]
2. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
4. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
Attman PO; Samuelsson O; Alaupovic P
Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
[TBL] [Abstract][Full Text] [Related]
5. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
6. The compositional abnormalities of lipoproteins in diabetic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephrol Dial Transplant; 1994; 9(11):1580-5. PubMed ID: 7870346
[TBL] [Abstract][Full Text] [Related]
8. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Weiss L; Alaupovic P
J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
[TBL] [Abstract][Full Text] [Related]
9. Human intestinal lipoproteins. Studies in chyluric subjects.
Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
Alaupovic P; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Samuelsson O
Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
[TBL] [Abstract][Full Text] [Related]
11. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
[TBL] [Abstract][Full Text] [Related]
13. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
14. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
15. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein metabolism and renal failure.
Attman PO; Samuelsson O; Alaupovic P
Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
[TBL] [Abstract][Full Text] [Related]
18. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
[TBL] [Abstract][Full Text] [Related]
19. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
20. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system.
Ripollés Piquer B; Nazih H; Bourreille A; Segain JP; Huvelin JM; Galmiche JP; Bard JM
Metabolism; 2006 Jul; 55(7):980-8. PubMed ID: 16784973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]